Cancer, Malaria & TB Vaccines
Malaria continues to claim an estimated 2 to 3 million lives annually and to account for untold morbidity in the approximately 300 to 500 million people infected annually. Malaria is considered a re-emerging disease, due largely to the spread of drug-resistant parasite strains, decay of health-care infrastructure and difficulties in implementing and maintaining vector control programs in many developing countries. Four species of protozoan parasites cause malaria in humans: Plasmodium falciparum, P. vivax, P. malariae, and P. ovale. P. falciparum is responsible for the majority of deaths and most of the severe forms of disease, including cerebral malaria. 2 billion people latently infected with M. tuberculosis 5-10% infected people progress to disease 9 million new TB cases each year 1.5 million TB deaths each year Equivalent to 20 passenger aircraft crashes each day. TB is transmitted by adults with cavitatory disease HIV infected people carry greater burden of disease. Highest risk of progression from TB infection to active disease, and worst TB morbidity and mortality, compared to older children and adults.
Related Conference of Cancer, Malaria & TB Vaccines
Cancer, Malaria & TB Vaccines Conference Speakers
Recommended Sessions
- Animal & Plant Derived Vaccines
- Animal Models & Clinical Trials
- Antibodies: Engineering & Therapeutics
- Cancer, Malaria & TB Vaccines
- Cellular Immunology & Latest Innovations
- Combination & Conjugate Vaccines
- Current Research & Future Challenges
- DNA & Synthetic Vaccines
- Fish & Poultry Vaccines
- Geriatric Immunization
- HIV Vaccines
- Paediatric Vaccination
- Travel & Edible Vaccines
- Vaccine Production & Development
- Vaccine Safety & Efficacy
- Vaccines & Autism
- Vaccines against Drugs‎
- Vaccines against Infectious Diseases
- Vaccines for Immune Mediated Diseases
- Vaccines for Pregnant Women & Neonates
- Vaccines for Unconventional Diseases
- Vectors, Adjuvants & Delivery Systems
Related Journals
Are you interested in
- Adaptive Immunity, Memory Formation & T-Cell Engineering - European Immunology 2026 (France)
- Advances in Neuroimaging and Diagnostic Techniques - Neuroimmunology Congress 2026 (Italy)
- Advances in Neuroimmunology and Neuroinflammation - Neuroimmunology Congress 2026 (Italy)
- Allergy, Hypersensitivity & Immune Tolerance - Immunology 2026 (France)
- Allergy, Hypersensitivity & Immune Tolerance Strategies - European Immunology 2026 (France)
- Artificial Intelligence and Data-Driven Approaches in Neuroimmunology - Neuroimmunology Congress 2026 (Italy)
- Autoimmune & Inflammatory Disorders - Immunology 2026 (France)
- Autoimmune Neurological Disorders and Therapeutic Advances - Neuroimmunology Congress 2026 (Italy)
- Autoimmunity Mechanisms & Precision Immunoregulation - European Immunology 2026 (France)
- Biomarkers and Precision Medicine in Neuroimmune Disorders - Neuroimmunology Congress 2026 (Italy)
- Cancer Immunology & Tumor Microenvironment - Immunology 2026 (France)
- Case Studies and Clinical Practice in Neuroimmunology and Neuroinfectious Diseases - Neuroimmunology Congress 2026 (Italy)
- Cellular Signaling & Cell Fate Determination - Immunology 2026 (France)
- Clinical and Translational Immunology - Immunology 2026 (France)
- Clinical Trials and Drug Development in Neuroimmunology - Neuroimmunology Congress 2026 (Italy)
- CNS Infections: Diagnosis, Management, and Prevention - Neuroimmunology Congress 2026 (Italy)
- Computational Immunology, AI Modeling & Immune System Simulation - European Immunology 2026 (France)
- Cytokine Signaling Networks & Immune Modulation - European Immunology 2026 (France)
- Emerging Technologies and Future Directions in Neuroimmunology - Neuroimmunology Congress 2026 (Italy)
- Ethical Considerations and Future Perspectives in Neuroimmunology Research - Neuroimmunology Congress 2026 (Italy)
- Immune Cell Reprogramming & Gene-Edited Immunotherapies - European Immunology 2026 (France)
- Immunogenetics & Epigenetic Regulation - Immunology 2026 (France)
- Immunogenetics and Neuroimmune Interactions - Neuroimmunology Congress 2026 (Italy)
- Immunometabolism - Immunology 2026 (France)
- Immunometabolism & Cellular Energy Dynamics - European Immunology 2026 (France)
- Immunotherapy & Immune Modulation - Immunology 2026 (France)
- Immunotherapy and Novel Treatment Strategies - Neuroimmunology Congress 2026 (Italy)
- Infectious Diseases & Host–Pathogen Interactions - Immunology 2026 (France)
- Inflammation Biology & Chronic Immune Disorders - European Immunology 2026 (France)
- Innate and Adaptive Immune Mechanisms - Immunology 2026 (France)
- Innate Immune Sensors, Pattern Recognition & Host Defense - European Immunology 2026 (France)
- Innovations in Cell Biology & Imaging Technologies - Immunology 2026 (France)
- Microbiome and the Gut-Brain-Immune Axis - Neuroimmunology Congress 2026 (Italy)
- Microbiome–Immune Axis & Host Interaction Pathways - European Immunology 2026 (France)
- Molecular & Cellular Immunology - Immunology 2026 (France)
- Mucosal Immunity & Barrier Protection Mechanisms - European Immunology 2026 (France)
- Nanotechnology-Enabled Immune Delivery Systems - European Immunology 2026 (France)
- Neurodegeneration and Immune System Interactions - Neuroimmunology Congress 2026 (Italy)
- Neuroimmunology & Brain–Immune Interactions - Immunology 2026 (France)
- Neuroimmunology in Pediatric Disorders - Neuroimmunology Congress 2026 (Italy)
- Neuroinfectious Diseases and Global Health Challenges - Neuroimmunology Congress 2026 (Italy)
- Next-Generation Vaccines & Antigen Engineering - European Immunology 2026 (France)
- Public Health, Policy, and Global Collaboration in Neuroimmunology - Neuroimmunology Congress 2026 (Italy)
- Rehabilitation and Long-Term Management of Neuroimmune Disorders - Neuroimmunology Congress 2026 (Italy)
- Stem Cells & Regenerative Immunology - Immunology 2026 (France)
- Translational Research and Clinical Applications in Neuroimmunology - Neuroimmunology Congress 2026 (Italy)
- Tumor Immunology & Personalized Cancer Immunotherapies - European Immunology 2026 (France)
- Vaccines & Vaccine Technology - Immunology 2026 (France)
- Viral Immunology, Emerging Pathogens & Host Response - European Immunology 2026 (France)
- Young Researchers, Innovation, and Emerging Ideas - Neuroimmunology Congress 2026 (Italy)
